Phase I trial of PXS LOXi for Pancreatic cancer
Phase of Trial: Phase I
Latest Information Update: 22 Feb 2019
Price : $35 *
At a glance
- Drugs Protein-lysine 6-oxidase inhibitors (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 22 Feb 2019 According to a Pharmaxis media release, first patient has been dosed in the trial, results are due to report in June 2019.
- 22 Feb 2019 Status changed from planning to recruiting, according to a Pharmaxis media release.
- 04 Dec 2018 New trial record